Miocardiopatía dilatada

  1. García Acuña, José María
  2. López Lago, A.
  3. González Juanatey, José Ramón
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2013

Series: 11

Issue: 42

Pages: 2500-2506

Type: Article

DOI: 10.1016/S0304-5412(13)70654-1 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Sustainable development goals

Abstract

Dilated cardiomyopathy (DCM) is a form of miocardium disease characterized by impaired function and ventricular dilation of the left, or both, ventricles. DCM is inherited in at least 30-40% of cases. Symptoms in patients with DCM are similar to that of patients with different etiology heart failure. Although echocardiography is the diagnostic tool that provides more information other techniques, such as coronariography and MRI, give information about the etiology. Biopsy is reserved to selected cases. Therapeutic improvements that have taken place over the past decades (inhibitors of angiotensin converting enzyme, beta-blockers, aldosterone antagonists), have contributed to improve the prognosis. If pharmacological treatment fails cardiac transplantation may be indicated.

Bibliographic References

  • Abraham WT, Fisher Wg, Smith Al, Delurgio DB, Leon AR, Loh E. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-53.
  • Acquatella H. Miocardiopatía dilatada: avances recientes y tratamiento actual. Rev EspCardiol. 2000; 53 (Supl 1):19-27.
  • Baig MK, Goldman JH, Caforio Al, Coonar AS, Keeling PJ, McKenna WJ. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatyc relatives and and may represent early disease. J Am Coll Cardiol. 1998;35:195-201.
  • Cicoria M, Zanolla L, Latina L, Rossi A, Golia G, Brighetti G. Frequency, prognosis and predictorof improvement of left ventricular function in patients with classical clinical diagnosis of idiopathic dilated cardiomiopathy. Eur J Heart Fail. 2001;3:323-30.
  • Drazner MH, Rame JE, Phil M, Stevenson LW, Stevenson LW, Dries. DL. Pronostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Eng J Med. 2001;345:574-81.
  • Hess OM, McKenna W, Schultheiss HP. Myocardial Disease. The ESC Textbook of Cardiovascular Medicine. Oxford: Oxford University Press; 2009. p. 665-716.
  • Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D. Hight prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation. 2005;111:887-93.
  • Mahon NG, Madden BP, Caforio AL, Elliott PM, Haven AJ, Keogh BE. Inmunohistologic evidence of myocardial disease in apparently healthy relative of patients with dilated cardiomyopathy. J Am Coll Cardiol. 2002,39:455-62.
  • Maron BJ, Towbin JA, Thiene G, Antzelevich Ch, Corrado D, Arnett D. Contemporany definitions aand classification of the cardiomyopathies. Circulation. 2006;113:1807-16.
  • Mason JW. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovas Res. 2003;60:5-10.
  • McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K. ESC Guidelines for the diagnosis and treatmentof acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33: 1787-847.
  • Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of European Human and Capital Mobility Projet of Familial Dilated Cardiomyopathy. Eur Heart J. 1999;20:93-102.
  • Michels VV, Driscoll DJ, Miller FA, Olson TM, Atkinson EJ, Olswold CL. Progression of familial and non familial dilated cardomyopathy: a long term follow up. Heart. 2003;89:757-61.
  • Navarro-López F. Miocardiopatía hipertrófica: la complejidad que no cesa. Rev Esp Cardiol. 2006;59(10):994-6.02 ACT 1 (2500-2506). indd 250623/10/13 11:50
  • Towbin JA, Bowles NE. The failing heart. Nature. 2002; 415:227-33.
  • Yacoub MH. A novel strategy to maximize the efficacy of left ventricular assist devices as a brigde to recovery. Eur Heart J. 2001;22:534-40.
Data source: Dialnet